Marco Colonna Selected Research

Interleukin-6 (Interleukin 6)

1/2022	Dysregulation of the leukocyte signaling landscape during acute COVID-19.
1/2015	Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection.
12/2007	LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells.
3/2006	Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Colonna Research Topics

Disease

45	Infections 05/2024 - 12/2002
41	Neoplasms (Cancer) 05/2024 - 10/2004
31	Inflammation (Inflammations) 04/2024 - 06/2003
21	Virus Diseases (Viral Diseases) 12/2021 - 02/2002
17	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 03/2015
10	Melanoma (Melanoma, Malignant) 10/2014 - 06/2003
8	Colitis 05/2024 - 01/2008
6	Neuroinflammatory Diseases 04/2024 - 01/2016
6	Bacterial Infections (Bacterial Infection) 01/2021 - 02/2009
4	Demyelinating Diseases (Demyelinating Disease) 12/2023 - 02/2012
4	Wounds and Injuries (Trauma) 01/2023 - 01/2009
4	Autoimmune Diseases (Autoimmune Disease) 05/2016 - 07/2007
4	Sepsis (Septicemia) 01/2016 - 06/2003
3	Crohn Disease (Crohn's Disease) 05/2024 - 01/2008
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 11/2010
3	Dysbiosis 01/2024 - 01/2019
3	Clostridium Infections 01/2024 - 01/2020
3	Atherosclerosis 01/2022 - 04/2012
3	Amyloid Plaque 01/2022 - 01/2018
3	Neoplasm Metastasis (Metastasis) 04/2016 - 01/2010
2	Retinal Degeneration 03/2024 - 07/2023
2	Atrophy 03/2024 - 07/2023
2	Cystitis 01/2023 - 11/2014
2	Pneumonia (Pneumonitis) 11/2022 - 01/2016
2	Intestinal Diseases (Diseases, Intestinal) 11/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 09/2022 - 11/2019
2	Body Weight (Weight, Body) 01/2021 - 03/2007
2	Asthma (Bronchial Asthma) 01/2020 - 07/2007
2	Parasitic Diseases (Parasitic Disease) 01/2019 - 04/2014
2	Acute-Phase Reaction 01/2019 - 08/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 12/2016
2	Malaria 12/2017 - 06/2013
2	Reinfection 10/2016 - 11/2014
2	Multiple Myeloma 07/2015 - 05/2015
2	Persistent Infection 01/2015 - 03/2004
2	Pneumococcal Pneumonia 08/2014 - 06/2014
2	Carcinogenesis 05/2014 - 03/2009
2	Confusion (Bewilderment) 04/2011 - 01/2011

Drug/Important Bio-Agent (IBA)

30	CytokinesIBA 05/2024 - 04/2003
20	LigandsIBA 11/2021 - 06/2003
12	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2016
11	Interleukin-22 (IL-22)IBA 05/2024 - 02/2009
11	Proteins (Proteins, Gene)FDA Link 12/2019 - 06/2003
9	AntigensIBA 11/2022 - 04/2003
8	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2009
7	LipidsIBA 09/2022 - 03/2015
7	Interferon Type IIBA 01/2021 - 02/2002
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2004
6	Cell Surface ReceptorsIBA 04/2024 - 08/2005
6	InterferonsIBA 01/2023 - 05/2010
6	ChemokinesIBA 01/2019 - 06/2003
6	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2016 - 06/2003
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 10/2016
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
5	NK Cell Lectin-Like Receptor Subfamily KIBA 05/2011 - 08/2005
4	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2022
4	VaccinesIBA 02/2024 - 05/2011
4	Interleukin-13IBA 11/2022 - 01/2009
4	Peptides (Polypeptides)IBA 11/2022 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2006
4	AntibodiesIBA 01/2022 - 06/2004
4	Interleukin-17 (Interleukin 17)IBA 10/2019 - 08/2013
4	class-I restricted T cell-associated moleculeIBA 01/2019 - 08/2005
4	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 08/2005
4	Poly I-CIBA 10/2014 - 11/2008
4	Triggering Receptor Expressed on Myeloid Cells-1IBA 08/2014 - 12/2004
3	Chemokine ReceptorsIBA 02/2024 - 01/2018
3	CuprizoneIBA 12/2023 - 05/2015
3	InterleukinsIBA 11/2022 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2013
3	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2016
3	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 09/2003
3	Natural Killer Cell ReceptorsIBA 01/2019 - 10/2006
3	AutoantigensIBA 01/2018 - 04/2011
3	Monoclonal AntibodiesIBA 04/2016 - 12/2002
3	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 04/2015 - 12/2002
3	Viral RNAIBA 04/2011 - 02/2010
2	Interleukin-12 (IL 12)IBA 05/2024 - 12/2007
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2024 - 08/2023
2	Galectin 3 (LGALS3)IBA 03/2024 - 07/2023
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2023 - 11/2014
2	Apolipoproteins E (ApoE)IBA 10/2022 - 01/2018
2	lipoarabinomannan (LAM)IBA 09/2022 - 01/2019
2	NucleotidesIBA 04/2021 - 10/2014
2	Small Cytoplasmic RNAIBA 01/2021 - 01/2020
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2019 - 01/2019
2	Interleukin-4 (Interleukin 4)IBA 01/2019 - 01/2009
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2015 - 01/2008
2	CD226 antigenIBA 01/2015 - 06/2013
2	LipopolysaccharidesIBA 05/2014 - 08/2005
2	chenodeoxycholate sulfate conjugate (CDCS)IBA 09/2013 - 01/2011
2	flt3 ligand protein (flt3 ligand)IBA 06/2013 - 12/2008
2	RNA Helicases (RNA Helicase)IBA 05/2013 - 11/2008
2	PerforinIBA 01/2010 - 10/2004
2	Toll-Like Receptor 3IBA 12/2009 - 05/2006
2	NectinsIBA 03/2009 - 10/2006

Therapy/Procedure

21	Therapeutics 01/2024 - 03/2004
10	Immunotherapy 05/2024 - 01/2015
3	Hematopoietic Stem Cell Transplantation 04/2024 - 11/2010